| Date | Time | Source | Headline | Symbol | Company |
| 09/06/2021 | 12:21PM | UK Regulatory | MaxCyte, Inc. Issue of Equity and Total Voting Rights | LSE:MXCT | Maxcyte Inc |
| 09/02/2021 | 9:26AM | UK Regulatory | MaxCyte, Inc. Notice of Results | LSE:MXCT | Maxcyte Inc |
| 08/10/2021 | 2:00AM | UK Regulatory | MaxCyte, Inc. Grant of Options | LSE:MXCT | Maxcyte Inc |
| 08/09/2021 | 2:00AM | UK Regulatory | MaxCyte, Inc. License with Sana Biotechnology | LSE:MXCT | Maxcyte Inc |
| 08/09/2021 | 2:00AM | PR Newswire (US) | MaxCyte Signs Clinical and Commercial License with Sana Biotechnology | LSE:MXCT | Maxcyte Inc |
| 08/05/2021 | 11:05AM | UK Regulatory | MaxCyte, Inc. Amendments to Bylaws | LSE:MXCT | Maxcyte Inc |
| 08/03/2021 | 10:51AM | UK Regulatory | MaxCyte, Inc. Closing of Offering | LSE:MXCT | Maxcyte Inc |
| 08/02/2021 | 4:22PM | Alliance News |  IN BRIEF: MaxCyte underwriters exercise over-allotment option | LSE:MXCT | Maxcyte Inc |
| 08/02/2021 | 2:00AM | UK Regulatory | MaxCyte, Inc. Full Exercise of Over-Allotment Option | LSE:MXCT | Maxcyte Inc |
| 07/30/2021 | 3:39PM | Alliance News | TRADING UPDATES: Cambria Automobiles suitor tables improved offer | LSE:MXCT | Maxcyte Inc |
| 07/30/2021 | 11:43AM | UK Regulatory | MaxCyte, Inc. Second Price Monitoring Extn | LSE:MXCT | Maxcyte Inc |
| 07/30/2021 | 11:36AM | UK Regulatory | MaxCyte, Inc. Price Monitoring Extension | LSE:MXCT | Maxcyte Inc |
| 07/30/2021 | 11:07AM | PR Newswire (US) | DLA Piper advises underwriters of MaxCyte's upsized US IPO | LSE:MXCT | Maxcyte Inc |
| 07/30/2021 | 2:00AM | UK Regulatory | MaxCyte, Inc. Pricing of Offering and Approval to List on Nasdaq | LSE:MXCT | Maxcyte Inc |
| 07/29/2021 | 11:05PM | PR Newswire (US) | MaxCyte Announces Pricing of Upsized Offering and Approval to List on the Nasdaq Global Select Market | LSE:MXCT | Maxcyte Inc |
| 07/29/2021 | 10:42PM | PR Newswire (US) | MaxCyte Announces Pricing of Upsized Offering and Approval to List on the Nasdaq Global Select Market | LSE:MXCT | Maxcyte Inc |
| 07/26/2021 | 3:23PM | Alliance News | TRADING UPDATES: Attraqt and tinyBuild trade in line in first half | LSE:MXCT | Maxcyte Inc |
| 07/26/2021 | 7:49AM | PR Newswire (US) | MaxCyte Announces Launch of Offering and Application to List on the Nasdaq Global Market | LSE:MXCT | Maxcyte Inc |
| 07/26/2021 | 6:14AM | UK Regulatory | MaxCyte, Inc. Launch of Offering and Application to List | LSE:MXCT | Maxcyte Inc |
| 07/19/2021 | 4:48PM | Alliance News | IN BRIEF: MaxCyte makes administrative changes ahead of Nasdaq listing | LSE:MXCT | Maxcyte Inc |
| 07/19/2021 | 7:30AM | UK Regulatory | MaxCyte, Inc. Termination of DI facility and transition to CDI | LSE:MXCT | Maxcyte Inc |
| 07/12/2021 | 3:26PM | Alliance News | IN BRIEF: Maxcyte files for dual listing on Nasdaq Global | LSE:MXCT | Maxcyte Inc |
| 07/12/2021 | 11:20AM | Alliance News | EXECUTIVE CHANGES: MP Evans CEO Price departs after 15 years | LSE:MXCT | Maxcyte Inc |
| 07/12/2021 | 2:00AM | UK Regulatory | MaxCyte, Inc. S-1 Financial information & Directorate Change | LSE:MXCT | Maxcyte Inc |
| 07/12/2021 | 2:00AM | PR Newswire (US) | Financial information in the Form S-1 registration statement and Change to Board of Directors | LSE:MXCT | Maxcyte Inc |
| 07/12/2021 | 2:00AM | PR Newswire (US) | MaxCyte Announces Public Filing of Registration Statement with SEC for a Proposed Nasdaq Dual Listing | LSE:MXCT | Maxcyte Inc |
| 07/12/2021 | 2:00AM | UK Regulatory | MaxCyte, Inc. Public Filing of Registration Statement with SEC | LSE:MXCT | Maxcyte Inc |
| 07/06/2021 | 12:36PM | UK Regulatory | MaxCyte, Inc. Result of Special Meeting | LSE:MXCT | Maxcyte Inc |
| 06/16/2021 | 2:01AM | UK Regulatory | MaxCyte, Inc. Publication of Annual Report and Accounts | LSE:MXCT | Maxcyte Inc |
| 06/16/2021 | 2:00AM | UK Regulatory | MaxCyte, Inc. Stockholder Circular and Notice of Special Meeting | LSE:MXCT | Maxcyte Inc |